Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Brian S. Meldrum"'
Publikováno v:
Epilepsy & Behavior. 71:165-173
This review summarizes the current knowledge about DBA/2 mice and genetically epilepsy-prone rats (GEPRs) and discusses the contribution of such animal models on the investigation of possible new therapeutic targets and new anticonvulsant compounds f
Publikováno v:
Journal of Neurochemistry. 62:1458-1467
The effect of the non-N-methyl-D-aspartate (non-NMDA) receptor antagonist 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride (GYKI 52466) on ischaemia-induced changes in the microdialysate and tissue concentrations of g
Autor:
Michael A. Rogawski, Brian S. Meldrum
Publikováno v:
Neurotherapeutics. 4:18-61
This review considers how recent advances in the physiology of ion channels and other potential molecular targets, in conjunction with new information on the genetics of idiopathic epilepsies, can be applied to the search for improved antiepileptic d
Publikováno v:
European Journal of Pharmacology. 476:3-16
Metabotropic glutamate (mGlu) receptors have multiple actions on neuronal excitability through G-protein-linked modifications of enzymes and ion channels. They act presynaptically to modify glutamatergic and gamma-aminobutyric acid (GABA)-ergic trans
Autor:
Vasso Episkopou, Benjamin J. Whalley, Antigoni Ekonomou, Heather Wood, Brian S. Meldrum, S Malas, Andrew Constanti, S Nishiguchi, M. Postlethwaite
Publikováno v:
Neuroscience. 119:421-432
Mutations in several classes of embryonically-expressed transcription factor genes are associated with behavioral disorders and epilepsies. However, there is little known about how such genetic and neurodevelopmental defects lead to brain dysfunction
Autor:
Nicoletta V Baloyianni, Michael S. Perkinton, Brian S. Meldrum, Marcus Rattray, Robert J. Williams, Sachin K. Suchak
Publikováno v:
Journal of Neurochemistry. 84:522-532
The excitatory amino acid transporters (EAAT) removes neurotransmitters glutamate and aspartate from the synaptic cleft. Most CNS glutamate uptake is mediated by EAAT2 into glia, though nerve terminals show evidence for uptake, through an unknown tra
Autor:
Brian S. Meldrum, Pierre Lestage, Hashim Al-Badri, Anita Roger, Astrid G. Chapman, Alex Cordi, Elisabeth Ruano, Claude Fugier, Patrice Desos, Jean-Yves Thomas
Publikováno v:
Il Farmaco. 57:787-802
We reported previously the synthesis and structure-activity relationships (SAR) in a series of 2-(1H)-oxoquinolines bearing different acidic functions in the 3-position. Exploiting these SAR, we were able to identify 6,7-dichloro-2-(1H)-oxoquinoline-
Autor:
Brian S. Meldrum
Publikováno v:
Epilepsy Research. 50:33-40
Classical screening tests (maximal electroshock, MES, and threshold pentylenetetrazol, PTZ) employ non-epileptic rodents and identify antiepileptic drugs (AEDs) with mechanisms of action associated with significant CNS side effects. Thus MES identifi
Publikováno v:
Journal of Neurochemistry. 78:13-23
The selective group-III metabotropic glutamate receptor agonist, L-serine-O-phosphate (L-SOP), when injected bilaterally into the inferior colliculus of the sound sensitive genetically epilepsy-prone (GEP) rats produces a short proconvulsant excitati
Autor:
Maria Jeffrey, Brian S. Meldrum, Philip M Beart, Ali Talebi, Astrid G. Chapman, Randal X. Moldrich
Publikováno v:
Neuropharmacology. 41:8-18
The selective group II metabotropic glutamate receptor (mGlu(2/3)) agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4 (LY389795) have been evaluated as anti-epileptic drugs in dilu